x

Search for a clinical trial

* (*) mandatory field

An open label extension study to investigate the safety of cannabidiol (GWP42003-P; CBD) in children and adults with inadequately controlled Dravet or Lennox-Gastaut Syndromes (Phase III) - ES (completed)

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Gw pharma ltd.
    • Phase : III
  • Sponsor of clinical trial

  • GW PHARMA LTD.
  • GW Pharma Ltd.
  • Porton Down Science Park
  • SALISBURY SP4 0JQ
  • UNITED KINGDOM
  • More information
  • Phone  : 44 (0)1980 557000
  • Fax  : 44 (0)1980 557111
  • Website
  • Contact secretary  :
Last update: March 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.